DDInter6 DDInter808
Abciximab is a Fab fragment of the chimeric human-murine monoclonal antibody 7E3. Abciximab binds to the glycoprotein (GP) IIb/IIIa receptor of human platelets and inhibits platelet aggregation by preventing the binding of fibrinogen, von Willebrand factor, and other adhesive molecules. It also binds to vitronectin (αvβ3) receptor found on platelets and vessel wall endothelial and smooth muscle cells.
Garlic allergenic extract is used in allergenic testing.
Abciximab {u} may cause a minor interaction that can limit clinical effects when taken with {v} Capsicum
Abciximab {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Iloprost
Abciximab {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Collagenase clostridium histolyticum
Abciximab {u} may lead to a major life threatening interaction when taken with {v} Tinzaparin
Abciximab {u} may lead to a major life threatening interaction when taken with {v} Reteplase
Abciximab may cause a minor interaction that can limit clinical effects when taken with Capsicum
Abciximab may cause a moderate interaction that could exacerbate diseases when taken with Iloprost
Abciximab may cause a moderate interaction that could exacerbate diseases when taken with Collagenase clostridium histolyticum
Abciximab may lead to a major life threatening interaction when taken with Tinzaparin
Abciximab may lead to a major life threatening interaction when taken with Reteplase